Cyprotex
Kerry Frost has held various roles in the field of pharmaceuticals and crop protection, serving as a Study Delivery Leader at Cyprotex since July 2008, a DMPK scientist at AstraZeneca from 2004 to 2008, a Metabolism scientist at Syngenta Crop Protection from 1996 to 2004, and completing an industrial placement at GlaxoSmithKline from 1994 to 1995.
This person is not in any offices
Cyprotex
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology